Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

Formation of the Platelet Plug

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

Coagulation

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

Vascular Spasm

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Fibrin is a thrombin sink that leads to stillness of thrombi.

Blood·2026

Same author

The mechanisms of contractile dysfunction following chronic limited platelet activation in (pro)thrombotic conditions.

Thrombosis research·2026

Same author

Contraction of blood clots occurs during hemostasis and hemorrhagic shock to promote closure of lacerations.

Biomaterials·2026

Same author

Early pregravid correction of hemostasis assessed by novel biomarkers improves the outcomes of pregnancies in women with bad obstetric history.

Clinical science (London, England : 1979)·2026

Same author

Response to Letter to the Editor: "Back to the drawing board: Exploring the composition and physical properties of traumatic hemothorax".

The journal of trauma and acute care surgery·2026

Same author

Protease-Activated Receptor-2 Promotes Metastasis: An Emerging Therapeutic Target.

Molecular cancer research : MCR·2026

Search research articles

Related Experiment Video

Updated: Jun 30, 2025

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Published on: June 15, 2011

Time-dependent ultrastructural changes during venous thrombogenesis and thrombus resolution.

Irina N Chernysh¹, Subhradip Mukhopadhyay², Tierra A Johnson³

¹Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Journal of Thrombosis and Haemostasis : JTH

|March 16, 2024

Summary

This summary is machine-generated.

Deep vein thrombosis (DVT) resolution involves dynamic cellular changes and distinct fibrin structures. Understanding these ultrastructural changes can inform diagnosis and improve thrombolytic treatments for better patient outcomes.

Keywords:

PAI-1 fibrin fibrinolysis scanning electron microscopy venous thrombosis

More Related Videos

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Published on: April 13, 2018

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Related Experiment Videos

Last Updated: Jun 30, 2025

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Published on: June 15, 2011

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Published on: April 13, 2018

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Area of Science:

Vascular biology
Thrombosis research
Ultrastructural pathology

Background:

Deep vein thrombosis (DVT) is a significant vascular event with potential for fatal pulmonary embolism.
Faster thrombus resolution correlates with improved patient prognosis, yet detailed structural changes during resolution remain poorly understood.

Purpose of the Study:

To define the spatial-morphologic characteristics of venous thrombus formation, propagation, and resolution at the submicron level over time.
To investigate the structural and compositional changes during DVT resolution using advanced microscopy techniques.

Main Methods:

Utilized a murine model of stasis-induced deep vein thrombosis.
Employed scanning electron microscopy and immunohistology to analyze thrombus structure and composition.
Compared thrombi in wild-type mice with those from plasminogen activator inhibitor type 1 (PAI-1) deficient mice.

Main Results:

Observed diverse fibrin structures and dynamic cellular changes (leukocytes, platelets, red blood cells) during thrombus resolution.
Identified intrathrombus microvesicles and polyhedrocytes (indicating clot contraction) not visible with standard histology.
Detected early fibrinolysis during thrombogenesis, accelerated in PAI-1 deficient mice.

Conclusions:

The study provides novel ultrastructural and compositional insights into DVT resolution.
These findings reveal dynamic changes during accelerated resolution, surpassing standard pathological methods.
The detailed insights can enhance diagnosis and guide the effectiveness of thrombolytic therapies for improved patient outcomes.